U.S. Burden of Cancer by Race and Ethnicity According to Disability-Adjusted Life Years

American Journal of Preventive Medicine

Volumn 51, Issue 5, 2016, Pages 673-681

  Lortet Tieulent, Joannie ^a   Soerjomataram, Isabelle ^b   Lin, Chun Chieh ^a   Coebergh, Jan Willem W ^c   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CAUCASIAN; CHILD; COLORECTAL CANCER; DISABILITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFECTION; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PANCREAS CANCER; QUALITY ADJUSTED LIFE YEAR; RACE DIFFERENCE; SEX DIFFERENCE; STOMACH CANCER; UNITED STATES; UTERINE CERVIX CANCER; VITAL STATISTICS; EPIDEMIOLOGY; ETHNOLOGY; INFANT; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; YOUNG ADULT;

EID: 84994152120     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.07.039     Document Type: Article

References (54)

1. 1 Doll, R., Boreham, J., Recent trends in cancer mortality in the UK. Br J Cancer 92:7 (2005), 1329–1335, 10.1038/sj.bjc.6602450.
2. 2 World Bank. World Development Report 1993—Investing In Health: World Development Indicators. 1993, World Bank, Oxford, UK.
3. 3 Moran, A.E., Forouzanfar, M.H., Roth, G.A., et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 129:14 (2014), 1493–1501, 10.1161/CIRCULATIONAHA.113.004046.
4. 4 Johnston, S.C., Mendis, S., Mathers, C.D., Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8:4 (2009), 345–354, 10.1016/S1474-4422(09)70023-7.
5. 5 Mathers, C.D., Vos, E.T., Stevenson, C.E., Begg, S.J., The burden of disease and injury in Australia. Bull World Health Organ 79:11 (2001), 1076–1084.
6. 6 Murthy, N.S., Nandakumar, B.S., Pruthvish, S., George, P.S., Mathew, A., Disability adjusted life years for cancer patients in India. Asian Pac J Cancer Prev 11:3 (2010), 633–640.
7. 7 Murray, C.J., Atkinson, C., Bhalla, K., et al. The state of U.S. health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310:6 (2013), 591–608, 10.1001/jama.2013.13805.
8. 8 World Health Organization. DALY estimates, 2000–2012. www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html. Published 2014. Accessed November 20, 2015.
9. 9 GBD 2013 DALYs and HALE Collaborators, Murray, C.J., Barber, R.M., et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386:10009 (2015), 2145–2191, 10.1016/S0140-6736(15)61340-X.
10. 10 Michaud, C.M., McKenna, M.T., Begg, S., et al. The burden of disease and injury in the United States 1996. Popul Health Metr, 4, 2006, 11, 10.1186/1478-7954-4-11.
11. 11 Howlader, N., Noone, A.M., Krapcho, M., et al. SEER Cancer Statistics Review, 1975−2011. 2014, National Cancer Institute, Bethesda, MD.
12. 12 Surveillance Epidemiology and End Results (SEER) Program. Research data (1973–2011). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. Released 2014 based on November 2013 submission.
13. 13 Surveillance Epidemiology and End Results (SEER) Program. Underlying mortality data provided by NCHS. SEER*Stat Database: Mortality—all COD, Total U.S. (1969–2011) . National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. 2014.
14. 14 Centers for Disease Control and Prevention. Deaths: final data for 2011. Natl Vital Stat Rep, 63(3), 2014.
15. 15 Soerjomataram, I., Lortet-Tieulent, J., Ferlay, J., et al. Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol, 12, 2012, 125, 10.1186/1471-2288-12-125.
16. 16 Global Burden of Disease Study. 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:9995 (2015), 743–800, 10.1016/S0140-6736(15)60692-4.
17. 17 Salomon, J.A., Vos, T., Hogan, D.R., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380:9859 (2012), 2129–2143, 10.1016/S0140-6736(12)61680-8.
18. 18 Klein, R.J., Schoenborn, C.A., Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes(20), 2001, 1–10.
19. 19 Greenland, S., Interval estimation by simulation as an alternative to and extension of confidence intervals. Int J Epidemiol 33:6 (2004), 1389–1397, 10.1093/ije/dyh276.
20. 20 U.S. DHHS. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. 2014, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA: U.S. DHHS.
21. 21 Zonderman, A.B., Ejiogu, N., Norbeck, J., Evans, M.K., The influence of health disparities on targeting cancer prevention efforts. Am J Prev Med 46:3 suppl 1 (2014), S87–S-97, 10.1016/j.amepre.2013.10.026.
22. 22 National Center for Health Statistics. Health, United States, 2013: With Special Feature on Prescription Drugs. 2014, National Center for Health Statistics, Hyattsville, MD.
23. 23 Smith, J., Medalia, C., Health Insurance Coverage in the United States: 2013. 2014, Census Bureau, Washington, DC: U.S.
24. 24 Pampel, F.C., Krueger, P.M., Denney, J.T., Socioeconomic disparities in health behaviors. Annu Rev Sociol 36 (2010), 349–370, 10.1146/annurev.soc.012809.102529.
25. 25 Louwman, W.J., Aarts, M.J., Houterman, S., van Lenthe, F.J., Coebergh, J.W., Janssen-Heijnen, M.L., A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 103:11 (2010), 1742–1748, 10.1038/sj.bjc.6605949.
26. 26 Slater, S.J., Ewing, R., Powell, L.M., Chaloupka, F.J., Johnston, L.D., O'Malley, P.M., The association between community physical activity settings and youth physical activity, obesity, and body mass index. J Adolesc Health 47:5 (2010), 496–503, 10.1016/j.jadohealth.2010.03.017.
27. 27 Larson, N.I., Story, M.T., Nelson, M.C., Neighborhood environments: disparities in access to healthy foods in the U.S. Am J Prev Med 36:1 (2009), 74–81, 10.1016/j.amepre.2008.09.025.
28. 28 Prizment, A.E., Yatsuya, H., Lutsey, P.L., et al. Smoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study. Am J Prev Med 46:6 (2014), 624–632, 10.1016/j.amepre.2014.01.017.
29. 29 Lansdorp-Vogelaar, I., Kuntz, K.M., Knudsen, A.B., van Ballegooijen, M., Zauber, A.G., Jemal, A., Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev 21:5 (2012), 728–736, 10.1158/1055-9965.EPI-12-0023.
30. 30 Iqbal, J., Ginsburg, O., Rochon, P.A., Sun, P., Narod, S.A., Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:2 (2015), 165–173, 10.1001/jama.2014.17322.
31. 31 Merrill, R.M., Harris, J.D., Merrill, J.G., Differences in incidence rates and early detection of cancer among non-Hispanic and Hispanic whites in the United States. Ethn Dis 23:3 (2013), 349–355.
32. 32 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65:1 (2015), 5–29, 10.3322/caac.21254.
33. 33 Arnold, M., Razum, O., Coebergh, J.W., Cancer risk diversity in non-western migrants to Europe: an overview of the literature. Eur J Cancer 46:14 (2010), 2647–2659, 10.1016/j.ejca.2010.07.050.
34. 34 U.S. Census Bureau. The Hispanic population in the United States: 2012. 2013, Census Bureau, Washington, DC: U.S.
35. 35 Cokkinides, V.E., Bandi, P., Siegel, R.L., Jemal, A., Cancer-related risk factors and preventive measures in U.S. Hispanics/Latinos. CA Cancer J Clin 62:6 (2012), 353–363, 10.3322/caac.21155.
36. 36 Fedewa, S.A., Sauer, A.G., Siegel, R.L., Jemal, A., Prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev 24:4 (2015), 637–652, 10.1158/1055-9965.EPI-15-0134.
37. 37 Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data 2012−2013. 2013, Centers for Disease Control and Prevention, Atlanta, GA.
38. 38 Neuhouser, M.L., Thompson, B., Coronado, G.D., Solomon, C.C., Higher fat intake and lower fruit and vegetables intakes are associated with greater acculturation among Mexicans living in Washington State. J Am Diet Assoc 104:1 (2004), 51–57, 10.1016/j.jada.2003.10.015.
39. 39 World Cancer Research Fund, American Institute for Cancer Research. Diet and Cancer Report. 2007, World Cancer Research Fund, Washington, DC.
40. 40 Pinheiro, P.S., Sherman, R.L., Trapido, E.J., et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomarkers Prev 18:8 (2009), 2162–2169, 10.1158/1055-9965.EPI-09-0329.
41. 41 Gomez, S.L., Noone, A.M., Lichtensztajn, D.Y., et al. Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Inst 105:15 (2013), 1096–1110, 10.1093/jnci/djt157.
42. 42 Jin, H., Pinheiro, P.S., Xu, J., Amei, A., Cancer incidence among Asian American populations in the United States, 2009–2011. Int J Cancer 138:9 (2016), 2136–2145, 10.1002/ijc.29958.
43. 43 Walter, R.B., Brasky, T.M., Buckley, S.A., Potter, J.D., White, E., Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105:12 (2013), 860–868, 10.1093/jnci/djt102.
44. 44 Lipworth, L., Lagiou, P., Hsieh, C.C., Trichopoulos, D., Re: Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst, 105(22), 2013, 1762, 10.1093/jnci/djt285.
45. 45 Ma, J., Ward, E.M., Smith, R., Jemal, A., Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 119:7 (2013), 1381–1385, 10.1002/cncr.27813.
46. 46 Skolarus, T.A., Wolf, A.M., Erb, N.L., et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 64:4 (2014), 225–249, 10.3322/caac.21234.
47. 47 Sanda, M.G., Dunn, R.L., Michalski, J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:12 (2008), 1250–1261, 10.1056/NEJMoa074311.
48. 48 Brooks, R.A., Wright, J.D., Powell, M.A., et al. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol 114:1 (2009), 75–79, 10.1016/j.ygyno.2009.03.036.
49. 49 Khoder, W.Y., Waidelich, R., Buchner, A., Becker, A.J., Stief, C.G., Prospective comparison of one year follow-up outcomes for the open complete intrafascial retropubic versus interfascial nerve-sparing radical prostatectomy. Springerplus, 3, 2014, 335, 10.1186/2193-1801-3-335.
50. 50 Buchanan, N.D., Houston, K.A., Richardson, L.C., The essential role of public health in preventing disease, prolonging life, and promoting health of cancer survivors. Am J Prev Med 49:6S5 (2015), S467–S469.
51. 51 DeSantis, C.E., Lin, C.C., Mariotto, A.B., et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64:4 (2014), 252–271, 10.3322/caac.21235.
52. 52 Walker, J., Hansen, C.H., Martin, P., et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1:5 (2014), 343–350, 10.1016/S2215-0366(14)70313-X.
53. 53 Peeters, K.C., van de Velde, C.J., Leer, J.W., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23:25 (2005), 6199–6206, 10.1200/JCO.2005.14.779.
54. 54 Rowland, J.H., Bellizzi, K.M., Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol 32:24 (2014), 2662–2668, 10.1200/JCO.2014.55.8361.